Derm Dispatch: How Diet, Probiotics, and Gut Health Could Impact the Skin

In this episode of Derm Dispatch, Rajani Katta, MD, a board-certified dermatologist practicing in Houston, Texas, discussed the evolving relationship between the gut microbiome and dermatologic disease, highlighting the growing interest in prebiotics, probiotics, and dietary interventions as adjunctive tools in skin health management.

Katta began her discussion with Renata Block, DMSCc, MMS, PA-C, by distinguishing prebiotics from probiotics. Prebiotics are substances that promote the growth of beneficial gut microbes, with dietary fiber from fruits, vegetables, oats, onions, and garlic serving as key examples. Probiotics, by contrast, are live beneficial microorganisms commonly found in fermented foods such as yogurt, kefir, kimchi, sauerkraut, and miso. She emphasized that many cultures have long recognized fermented foods as important for overall health, long before modern microbiome science emerged.

The conversation focused heavily on the role of the microbiome in inflammatory skin disease, particularly atopic dermatitis (AD). Katta referenced a meta-analysis published in the New England Journal of Medicine showing that prebiotics and probiotics were generally beneficial in adults and children older than one year with AD. However, she noted substantial variability among studies, including differences in bacterial strains, dosages, treatment durations, and patient responses, making definitive clinical recommendations difficult.

Among the most studied probiotic strains are Lactobacillus and Bifidobacterium species, with Akkermansia emerging as another area of interest. Katta suggested that future dermatologic care may involve individualized microbiome analysis to tailor probiotic recommendations to each patient.

“I suspect eventually we will get to the point where we are doing a microbiome analysis on an individual patient, and then that analysis is guiding our recommendations,” Katta said. “I suspect it's not a one-size-fits-all approach, but we don't have the data right now.”

The discussion also addressed broader implications of microbiome research in dermatology. Katta highlighted evidence suggesting probiotics may improve acne outcomes when combined with oral antibiotics and cited studies linking rosacea to small intestinal bacterial overgrowth (SIBO), with some patients experiencing prolonged remission following treatment of underlying gut dysbiosis.

Despite enthusiasm surrounding probiotics, Katta cautioned that supplementation is not universally beneficial. She emphasized that probiotics may carry risks in immunosuppressed or severely ill patients and noted emerging data suggesting probiotics may delay restoration of the native gut microbiome following antibiotic use.

Throughout the discussion, Katta stressed the importance of a holistic, evidence-based approach that prioritizes whole-food dietary patterns, skin barrier support, and individualized patient care. She also underscored the need for dermatologists to provide balanced, scientifically grounded guidance amid the growing volume of online misinformation surrounding the microbiome and skin health.

“We have a duty to be out there and to provide our patients reliable resources and information, where they could be educated and take the right path,” Block agreed. “But most importantly, they should be consulting with their providers.”

Like this podcast, have suggestions, or want to participate in future episodes? Contact our team at [email protected].